2023
Single-center long-term results of vagus nerve stimulation for pediatric epilepsy: a 10-17-year follow-up study
CHRASTINA, Jan, Ondřej HORÁK, Michal RYZÍ, Milan BRÁZDIL, Zdeněk NOVÁK et. al.Základní údaje
Originální název
Single-center long-term results of vagus nerve stimulation for pediatric epilepsy: a 10-17-year follow-up study
Autoři
CHRASTINA, Jan (203 Česká republika, garant, domácí), Ondřej HORÁK (203 Česká republika, domácí), Michal RYZÍ (203 Česká republika, domácí), Milan BRÁZDIL (203 Česká republika, domácí), Zdeněk NOVÁK (203 Česká republika, domácí), Tomáš ZEMAN (203 Česká republika, domácí) a Pavlína DANHOFER (203 Česká republika, domácí)
Vydání
Childs nervous system, NEW YORK, SPRINGER, 2023, 0256-7040
Další údaje
Jazyk
angličtina
Typ výsledku
Článek v odborném periodiku
Obor
30210 Clinical neurology
Stát vydavatele
Spojené státy
Utajení
není předmětem státního či obchodního tajemství
Odkazy
Impakt faktor
Impact factor: 1.400 v roce 2022
Kód RIV
RIV/00216224:14110/23:00134637
Organizační jednotka
Lékařská fakulta
UT WoS
000992036000001
Klíčová slova anglicky
Seizure; Stimulation treatment; Stimulation responder; Palliative surgery
Příznaky
Mezinárodní význam, Recenzováno
Změněno: 14. 2. 2024 19:56, Mgr. Eva Dubská
Anotace
V originále
PurposeA retrospective study, based on a prospectively built database, presents the results of long-term follow-up care of pediatric vagus nerve stimulation (VNS) patients in terms of seizure outcome, surgical aspects, the potential impact of maturation, and medication changes.MethodsFrom a prospectively built database, 16 VNS patients (median age 12.0 years, range 6.0 to 16.0 years; median seizure duration 6.5 years, range 2.0 to 15.5 years) followed for at least 10 years were graded as non-responder - NR (seizure frequency reduction < 50%), responder - R (reduction >= 50% and < 80%), and 80% responder - 80R (reduction >= 80%). Data about surgical aspects (battery replacement, system complications), seizure dynamics, and medication changes were taken from the database.ResultsThe early percentages of good results (80R + R) were 43.8% (year 1), 50.0% (year 2), and 43.8% (year 3). These percentages remained stable between years 10 and 12 (50% year 10; 46.7% year 11; 50% year 12) and increased in years 16 (60%) and 17 (75%). Depleted batteries were replaced in ten patients, six of whom were either R or 80R. In the four NR, the indication for replacement was improved quality of life. Three patients had VNS explanted or switched off-one had repeated asystolia and two were NR. The effect of hormonal changes in menarche on seizure was not proven. During the study, antiseizure medication was changed in all patients.ConclusionsThe study proved the efficacy and safety of VNS in pediatric patients over an exceptionally long follow-up period. The demand for battery replacements indicates a positive treatment effect.
Návaznosti
NV19-04-00343, projekt VaV |
|